![Mette Agger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mette Agger
Directeur/Membre du Conseil chez
LEXEO THERAPEUTICS, INC.
Fortune : - $ au 31/05/2026
Profil
Mette Kirstine Agger was the founder of 7TM A, founded in 2000, and served as Chief Executive Officer from 2000 to 2009.
Current jobs include Chairman at KLIFO A; Director at C.W.
Obel A since 2018; Director at DYSIS Medical Ltd.; Director at Statens Serum Institute; Director at Akamis Bio Ltd.; Director at Cydan LLC; Director at Tiburio Therapeutics, Inc. since 2018; Independent Director at Lexeo Therapeutics, Inc. since 2020; and Managing Partner at Lundbeckfonden Ventures since 2012.
Former jobs include Deputy Chairman at Veloxis Pharmaceuticals A from 2016 to 2018; Chairman at Sophion Bioscience A; Director at ChemoMetec A; Director at Thesan Pharmaceuticals, Inc.; Director-Business Development at NTG Nordic Transport Group A from 1996 to 2000; Independent Director at Harboes Bryggeri A from 2008 to 2014; Director at CMC; Director at Symbion A; Director at DBV Technologies SA; Director at AlloCure, Inc.; Director at EpiTherapeutics ApS; Independent Director at Trevi Therapeutics, Inc. from 2017 to 2019; Director at Cydan II, Inc. from 2017 to 2021; Director at Abzu ApS; Director at Vtesse, Inc.; Independent Director at Imara, Inc. from 2016 to 2021; Independent Director at scPharmaceuticals, Inc. from 2014 to 2025; and Principal at Plougmann, Vingtoft & Partners A. Education includes an MBA from Henley Business School Ltd. and undergraduate studies at the University of Copenhagen.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Mette Agger
| Sociétés | Poste | Début |
|---|---|---|
| LEXEO THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/11/2020 |
DYSIS Medical Ltd.
 DYSIS Medical Ltd. Medical SpecialtiesHealth Technology Manufactures and distributes technological medical equipment for cervical cancer diagnostics | Directeur/Membre du Conseil | 01/05/2021 |
C.W. Obel A/S
 C.W. Obel A/S Investment ManagersFinance Functions as an alternative investment manager | Directeur/Membre du Conseil | 01/04/2018 |
Tiburio Therapeutics, Inc.
 Tiburio Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnological research and developmental services | Directeur/Membre du Conseil | 01/12/2018 |
Cydan LLC
 Cydan LLC Medical DistributorsDistribution Services Operates as an orphan drug accelerator that identifies and de-risks programs | Directeur/Membre du Conseil | - |
Akamis Bio Ltd.
 Akamis Bio Ltd. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that engages in development of tumor gene therapies | Directeur/Membre du Conseil | - |
Statens Serum Institute
 Statens Serum Institute Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | 02/06/2011 |
Lundbeckfonden Ventures
 Lundbeckfonden Ventures Investment ManagersFinance Lundbeckfonden Ventures is an active manager which provides equity funding for early and later-stage capital requirements, and provides management support. The firm targets companies operating in health technology sector, industries such as pharmaceuticals. Lundbeckfonden Ventures invests in companies located in Europe and North America, and looks to take minority stake positions in its investments, as well as a seat on the board. | Private Equity Investor | 16/09/2010 |
KLIFO A/S
 KLIFO A/S Miscellaneous Commercial ServicesCommercial Services Provides clinical research services | Président | - |
Anciens postes connus de Mette Agger
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Mette Agger
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
49
Relations au 1er degré
30
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 30 |
|---|---|
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for the prevention of organ rejection in kidney transplant patients | Health Technology |
ChemoMetec A/S
 ChemoMetec A/S Medical SpecialtiesHealth Technology Develops, manufactures and sells analytical equipment for the enumeration of cells in fluids | Health Technology |
Henley Business School Ltd.
 Henley Business School Ltd. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thesan Pharmaceuticals, Inc.
 Thesan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and produces novel therapeutics for skin disorders | Health Technology |
NTG Nordic Transport Group A/S
 NTG Nordic Transport Group A/S TruckingTransportation Transports goods through truck, ship and aircraft | Transportation |
Harboes Bryggeri A/S
 Harboes Bryggeri A/S Beverages: AlcoholicConsumer Non-Durables Engages in the production and sale of beer, soft drinks, malt beverages and malt wort products | Consumer Non-Durables |
C.W. Obel A/S
C.W. Obel A/S Investment ManagersFinance Functions as an alternative investment manager | Finance |
CMC
 CMC Miscellaneous Commercial ServicesCommercial Services Publishes music records | Commercial Services |
Symbion A/S
 Symbion A/S General GovernmentGovernment Provides office communities, meeting rooms, conference facilities, business development, and capital for start-up companies | Government |
DBV Technologies SA
 DBV Technologies SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that focuses on changing the field of immunotherapy | Health Technology |
KLIFO A/S
KLIFO A/S Miscellaneous Commercial ServicesCommercial Services Provides clinical research services | Commercial Services |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
7TM A/S
 7TM A/S BiotechnologyHealth Technology Operates as a biotech company that discovers and develops drugs | Health Technology |
Sophion Bioscience A/S
 Sophion Bioscience A/S Medical SpecialtiesHealth Technology Develops, manufactures and markets instruments and supplies automated patch clamping | Health Technology |
Plougmann, Vingtoft & Partners A/S | |
DYSIS Medical Ltd.
DYSIS Medical Ltd. Medical SpecialtiesHealth Technology Manufactures and distributes technological medical equipment for cervical cancer diagnostics | Health Technology |
AlloCure, Inc.
 AlloCure, Inc. BiotechnologyHealth Technology Develops cell therapies for the treatment of kidney diseases, organ transplants and multi-organ injuries | Health Technology |
EpiTherapeutics ApS
 EpiTherapeutics ApS Pharmaceuticals: MajorHealth Technology Develops cancer drugs based on epigenetics | Health Technology |
Statens Serum Institute
Statens Serum Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lundbeckfonden Ventures
Lundbeckfonden Ventures Investment ManagersFinance Lundbeckfonden Ventures is an active manager which provides equity funding for early and later-stage capital requirements, and provides management support. The firm targets companies operating in health technology sector, industries such as pharmaceuticals. Lundbeckfonden Ventures invests in companies located in Europe and North America, and looks to take minority stake positions in its investments, as well as a seat on the board. | Finance |
Akamis Bio Ltd.
Akamis Bio Ltd. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that engages in development of tumor gene therapies | Health Technology |
Trevi Therapeutics, Inc.
 Trevi Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of treatment for cough conditions | Health Technology |
Cydan II, Inc.
 Cydan II, Inc. Pharmaceuticals: GenericHealth Technology Develops and commercializes drugs | Health Technology |
Cydan LLC
Cydan LLC Medical DistributorsDistribution Services Operates as an orphan drug accelerator that identifies and de-risks programs | Distribution Services |
scPharmaceuticals, Inc.
 scPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products to the cardiovascular and infectious diseases | Health Technology |
Vtesse, Inc.
 Vtesse, Inc. BiotechnologyHealth Technology Engages in pre-clinical and clinical studies and develops drugs for patients suffering from diseases | Health Technology |
Imara, Inc.
 Imara, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes novel therapeutics for patients with sickle cell disease | Health Technology |
Abzu ApS
 Abzu ApS Packaged SoftwareTechnology Services Develops artificial Intelligence platform | Technology Services |
Tiburio Therapeutics, Inc.
Tiburio Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnological research and developmental services | Health Technology |
Lexeo Therapeutics Inc
 Lexeo Therapeutics Inc BiotechnologyHealth Technology Develops gene therapy to treat genetic diseases | Health Technology |
